NCT05028582: A reported trial by Arcutis Biotherapeutics, Inc.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT05028582 |
|---|---|
| Title | A Randomized tRial Employing topiCal roflumilasT Foam to Treat Scalp Psoriasis (ARRECTOR) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 24, 2021 |
| Completion date | June 3, 2022 |
| Required reporting date | June 3, 2025, midnight |
| Actual reporting date | May 28, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |